MCM
CRL icon

MV Capital Management’s Charles River Laboratories CRL Stock Holding History

MV Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
85
+7
+9% +$1.25K ﹤0.01% 465
2026
Q1 		$13.5K Buy
78
+1
+1% +$185 ﹤0.01% 489
2025
Q4 		$15.4K Hold
77
– – ﹤0.01% 474
2025
Q3 		$12K Buy
77
+4
+5% +$635 ﹤0.01% 493
2025
Q2 		$11.1K Buy
73
+35
+92% +$4.67K ﹤0.01% 510
2025
Q1 		$5.72K Buy
38
+17
+81% +$2.85K ﹤0.01% 599
2024
Q4 		$3.88K Sell
21
-5
-19% -$963 ﹤0.01% 632
2024
Q3 		$5.12K Sell
26
-3
-10% -$623 ﹤0.01% 625
2024
Q2 		$5.99K Buy
29
+5
+21% +$1.13K ﹤0.01% 588
2024
Q1 		$6.5K Buy
24
+1
+4% +$239 ﹤0.01% 574
2023
Q4 		$5.44K Buy
23
+8
+53% +$1.57K ﹤0.01% 592
2023
Q3 		$2.94K Hold
15
– – ﹤0.01% 625
2023
Q2 		$3.15K Buy
15
+7
+88% +$1.39K ﹤0.01% 620
2023
Q1 		$1.61K Buy
8
+1
+14% +$227 ﹤0.01% 653
2022
Q4 		$1.52K Buy
7
+1
+17% +$218 ﹤0.01% 624
2022
Q3 		$1K Hold
6
– – ﹤0.01% 648
2022
Q2 		$1K Sell
6
-5
-45% -$1.22K ﹤0.01% 644
2022
Q1 		$3K Buy
11
+8
+267% +$2.47K ﹤0.01% 629
2021
Q4 		$1K Sell
3
-4
-57% -$1.55K ﹤0.01% 674
2021
Q3 		$3K Buy
+7
New +$2.91K ﹤0.01% 636
2018
Q4 		– Sell
-45
Closed -$6K – 328
2018
Q3 		$6K Hold
45
– – ﹤0.01% 283
2018
Q2 		$5K Hold
45
– – ﹤0.01% 308
2018
Q1 		$5K Hold
45
– – ﹤0.01% 305
2017
Q4 		$5K Buy
+45
New +$4.9K ﹤0.01% 299

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

MV Capital Management's CRL Position: Q2 2026 in Review

MV Capital Management increased its Charles River Laboratories (CRL) stake by 9% in Q2 2026, buying an estimated $1.25K and bringing the position to 85 shares worth $19.3K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

MV Capital Management first reported a position in CRL in Q4 2017 and has held it in 24 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • MV Capital Management held 85 shares of Charles River Laboratories worth $19.3K as of Q2 2026.
  • MV Capital Management bought 7 Charles River Laboratories shares in Q2 2026, an estimated $1.25K.
  • Charles River Laboratories made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #465 holding.
  • MV Capital Management first reported a position in Charles River Laboratories in Q4 2017 and has held it in 24 quarters since.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.